Review of pharmacology of medications during pregnancy

被引：0

作者：

Pratt, Christy L. ^{[1
,2
]}

Hahn, Nicole M. ^{[1
,3
]}

机构：

[1] Kaiser Permanente Colorado, Pharm Dept, 16601 East Centretech Pkwy, Aurora, CO 80011 USA

[2] Kaiser Permanente Colorado, Primary Care & Obstet & Gynecol Dept, 280 Exempla Circle, Lafayette, CO 80026 USA

[3] Kaiser Permanente Colorado, Neurol Dept, 1375 E 20th Ave, Denver, CO 80205 USA

来源：

SEMINARS IN PERINATOLOGY | 2025年 / 49卷 / 04期

关键词：

Pharmacology; Pharmacokinetics; Pregnancy; Hypothyroidism; Depression; Epilepsy; SEROTONIN-REUPTAKE INHIBITORS; AMERICAN THYROID ASSOCIATION; WOMEN; MANAGEMENT; DISEASE; PHARMACOKINETICS; GUIDELINES; DISORDERS; DIAGNOSIS; EPILEPSY;

D O I：

10.1016/j.semperi.2025.152073

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Ninety percent of pregnant patients take at least one medication during pregnancy. Physiological changes during pregnancy can alter drug exposure. Understanding basic physiological principles including absorption, distribution, metabolism and excretion can guide medication management during pregnancy. While physiologic changes related to medications used to treat hypothyroidism, depression and epilepsy are highlighted in this article, the principles of pharmacokinetic changes during pregnancy can be applied to other medical conditions where less data may exist. Given the complexity of pharmacology, physiological changes of pregnancy, and nuances of managing medical conditions, a team approach to managing medications in pregnancy is recommended. Comprehensive care including general and specialized physicians, pharmacists, genetic counselors and more can help provide the most appropriate care to this multifaceted patient population.

引用

页数：6

共 48 条

[1] Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy [J].